AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Avantor Inc. (AVTR)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

17.54

-0.14 (-0.79%)

At close: Feb 20, 2025, 3:59 PM

17.49

-0.26%

After-hours: Feb 20, 2025, 07:00 PM EST

undefined% (undefined)

Bid	17.49
Market Cap	11.94B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	1.04
PE Ratio (ttm)	16.86
Forward PE	n/a
Analyst	Buy

Ask	17.8
Volume	3,274,405
Avg. Volume (20D)	5,429,449
Open	17.66
Previous Close	17.68
Day's Range	17.47 - 17.91
52-Week Range	17.14 - 28.00
Beta	undefined

About AVTR

Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography r...

[Show more]

Industry Chemicals - Specialty

Sector Basic Materials

IPO Date May 17, 2019

Employees 13,500

Stock Exchange NYSE

Ticker Symbol AVTR

Website https://www.avantorsciences.com

Full Company Profile

Analyst Forecast

According to 12 analyst ratings, the average rating for AVTR stock is "Buy." The 12-month stock price forecast is $25, which is an increase of 42.57% from the latest price.

Buy 75.00%

Hold 25.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Avantor Inc. is scheduled to release its earnings on Apr 25, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

-3.26%

Avantor shares are trading lower after multiple fi... Unlock content with Pro Subscription

1 week ago

-11.71%

Avantor shares are trading lower after the company reported Q4 financial results and missed its adjusted EPS estimate.

News

1 day ago · businesswire.com

Silq Technologies Corp. and NuSil Technology LLC Announce Collaboration Agreement to Drive Broad-based Adoption of Silq's Novel Surface Treatment Technology

SUNNY ISLES BEACH, Fla.--(BUSINESS WIRE)--Silq Technologies Corporation, a privately held advanced materials science company, and NuSil Technology LLC, a subsidiary of Avantor Inc., Radnor, Pa. (NYSE:...

1 week ago · zacks.com

Avantor Stock Declines Despite Q4 Earnings Beat, Margins Expand

Despite AVTR's stability in proprietary chemicals and specialty procurement sales, it reports an overall soft fourth-quarter performance.

1 week ago · seekingalpha.com

Avantor, Inc. (AVTR) Q4 2024 Earnings Call Transcript

Avantor, Inc. (NYSE:AVTR ) Q4 2024 Earnings Conference Call February 7, 2025 8:00 AM ET Company Participants Allison Hosak - SVP of Global Communications Michael Stubblefield - President and CEO Brent...

1 week ago · zacks.com

Avantor (AVTR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Avantor (AVTR) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Stre...

1 week ago · benzinga.com

Life Science Tools Firm Avantor Reports Mixed Q4 Earnings, Forecasts Organic Sales Growth In 2025

On Friday, Avantor Inc AVTR reported fourth-quarter net sales of $1.69 billion, a decrease of 2% year-over-year, missing the consensus of $1.71 billion.

1 week ago · zacks.com

Avantor, Inc. (AVTR) Surpasses Q4 Earnings Estimates

Avantor, Inc. (AVTR) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.25 per share a year ago.

2 weeks ago · businesswire.com

TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe

SAN DIEGO--(BUSINESS WIRE)--TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has partnered with, Avantor, I...

1 month ago · zacks.com

MD vs. AVTR: Which Stock Is the Better Value Option?

Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR). But which of these two stocks is more attractive to value inve...

1 month ago · zacks.com

MD vs. AVTR: Which Stock Should Value Investors Buy Now?

Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR). But which of these two companies is the best option for those ...

2 months ago · seekingalpha.com

Avantor: Durable FCF Generator Trading For Cheap

Avantor's robust business model yields stable cash flows and generates sticky customers. Avantor's leadership in the biopharma industry and shifting revenue mix can produce considerable margin expansi...

Load More News